Study of NGM707 in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies
Clinical trial NCT07511972 · WITHDRAWN
Trial details
- NCT number
- NCT07511972
- Sponsor
- NGM Biopharmaceuticals, Inc
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-14
- Primary completion
- 2024-12-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.